Drug Manufacturers—Specialty & Generic Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4814 | SNOA Sonoma Pharmaceuticals, Inc. - Common Stock | 1.16 USD | -4.92% | -9.38% | -10.77% | -58.12% | 5.55 M USD | ||
| 4860 | YCBD cbdMD, Inc. Common Stock | 0.39 USD | -4.88% | -13.33% | -18.75% | -45.07% | 4.37 M USD | ||
| 4896 | AKAN Akanda Corp. - Common Shares | 1.78 USD | -7.77% | -14.83% | -45.06% | -22.61% | 3.53 M USD | ||
| 4919 | RDHL Redhill Biopharma Ltd - American Depositary Shares | 0.58 USD | +23.40% | +16.00% | -17.14% | -42.57% | 2.95 M USD | ||
| 4946 | UPC Universe Pharmaceuticals Inc - Class A Ordinary Shares | 4.15 USD | -5.68% | -5.90% | +2.47% | -41.05% | 2.34 M USD | ||
| 4984 | SBFM Sunshine Biopharma Inc. - Common stock | 0.43 USD | -38.57% | -39.44% | -62.28% | -63.56% | 1.67 M USD | ||
| 5029 | PRFX PRF Technologies Ltd. - Ordinary Shares | 0.86 USD | -2.27% | -6.52% | -10.42% | -72.78% | 714.33 K USD | ||
| 5052 | IMCC IM Cannabis Corp. - Common Shares | 1.72 USD | -9.47% | -18.10% | -12.24% | -14.85% | 337.97 K USD | ||
| 5106 | SXTC China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares | 0.34 USD | -87.99% | -88.67% | -83.89% | -77.33% | 4 072.00 USD | ||
| 6683 | ALVOW Alvotech - Warrant | 0.4496 USD | 0.00% | +36.24% | +34.21% | -69.84% | 1.77 B USD | ||
| 7216 | BFRIW Biofrontera Inc. - Warrants | 0.0070 USD | -35.78% | -53.33% | -65.52% | -93.18% | 13.66 M USD | ||
| 7274 | SBFMW Sunshine Biopharma Inc. - Warrant | 0.0300 USD | -23.08% | +19.52% | -3.23% | -81.44% | 1.67 M USD |
Noticias Drug Manufacturers—Specialty & Generic Stocks
Jefferies rebaja la calificación de Pacira Pharmaceuticals por el acuerdo con Viatris
Informe de resultados: Tilray registra ingresos récord en el primer trimestre de 2027 mientras sus acciones caen
La acción de Pacira Pharmaceuticals alcanza su un máximo de 52 semanas en 36,32 dólares
Biofrontera solicita ampliar el uso de Ameluz para queratosis actínicas
China SXT Pharmaceuticals anuncia una oferta de acciones por 12 millones de dólares
¿Por qué se dispara hoy la acción de Pacira BioSciences?
Viatris adquirirá Pacira BioSciences por 1.650 millones de dólares
Gainers Drug Manufacturers—Specialty & Generic Stocks
Losers Drug Manufacturers—Specialty & Generic Stocks
SXTC China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares | 0.34 | -87.99% |
SBFM Sunshine Biopharma Inc. - Common stock | 0.43 | -38.57% |
BFRIW Biofrontera Inc. - Warrants | 0.0070 | -35.78% |
SBFMW Sunshine Biopharma Inc. - Warrant | 0.0300 | -23.08% |
SCYX SCYNEXIS, Inc. - Common Stock | 4.22 | -11.72% |
IMCC IM Cannabis Corp. - Common Shares | 1.72 | -9.47% |
AKAN Akanda Corp. - Common Shares | 1.78 | -7.77% |
AKBA Akebia Therapeutics, Inc. - Common Stock | 0.81 | -6.90% |